As I've posted on numerous occasions, the appeal for me to CDY has always been the midkine opportunity (rather than the retail side) after experience with PEB's CxBladder.
My increasing concerns about CDY's long term viability in the midkine space has been based on the longevity of their much vaunted "patent portfolio". Note the following information - which was published over 8 years ago ... and counting...
https://www.biospectrumasia.com/news/47/1471/cellmid-patent-for-midkine-protein-allowed-in-the-us.html
As we all know (or, at least, should know) ... the value of an intangible asset (and most especially - patents) decreases markedly as time marches on.
My questions would be....considering the above, why wasn't a specific capital raising undertaken (if one was necessary) in order to establish a suitable partnership so the maximum Midkine opportunity could be effected in a timely fashion? Why has the exciting Midkine potential been neglected (and the patents' potential wasted) over all these years?
Should I post my graphs again?
Add to My Watchlist
What is My Watchlist?
